Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tirzepatide
Biotech
A look at the R&D landscape in obesity, led by GLP-1s
If you’re feeling like the obesity pipeline filled up overnight, you’re not alone. A new analysis from IQVIA takes a look at the drugs in development.
Annalee Armstrong
,
Gabrielle Masson
Mar 19, 2024 8:00am
Lilly's obesity portfolio in 'all-of-the-above mode'
Nov 2, 2023 11:15am
Lilly, BioAge to test muscle regeneration drug with tirzepatide
Oct 26, 2023 11:39am
Lilly CMO: 'We need to leave J.P. Morgan and get back to work'
Jan 9, 2023 2:36pm
Lilly's tirzepatide clears high bar set by Novo in obesity
Apr 28, 2022 6:15am